申请人:Zhou Cangyou
公开号:US20050250814A1
公开(公告)日:2005-11-10
The present invention is directed to compounds of the formula I: (wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, W, X, Z, m and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
本发明涉及具有以下式I的化合物:(其中R1、R2、R3、R4、R5、R6、W、X、Z、m和n在此处定义),这些化合物可用作趋化因子受体活性的调节剂。特别是,这些化合物可用作趋化因子受体CCR-2的调节剂。